Understanding Fractional Shortening: Normal vs Optimal Ranges

?What is Fractional Shortening?

Fractional shortening is an echocardiographic measurement that quantifies the percentage decrease in left ventricular diameter during contraction. It is a simple, non-invasive index of systolic ventricular function derived from M-mode or 2D echocardiography. FS is calculated as the ratio of the change in left ventricular dimension to the end-diastolic dimension.

!Why It Matters

Fractional shortening is a practical indicator of left ventricular contractile performance and overall cardiac systolic function. Reduced FS may suggest impaired left ventricular systolic function and can be associated with heart failure, cardiomyopathy, or other cardiac disease, while elevated values are uncommon but can occur in hyperkinetic states. Serial measurements help clinicians monitor cardiac function over time and assess response to treatment.

Reference Ranges

Lab normal ranges may vary between laboratories. Optimal and longevity targets are based on research literature and should be interpreted with your physician.

Symptoms of Imbalance

• Shortness of breath or dyspnea
• Fatigue or reduced exercise tolerance
• Peripheral edema or fluid retention
• Chest discomfort or palpitations
• Syncope or lightheadedness

How to Improve Your Levels

• 1Optimize management of underlying conditions such as hypertension or diabetes
• 2Engage in moderate, supervised aerobic exercise as tolerated
• 3Maintain sodium and fluid restriction if advised by a cardiologist
• 4Take prescribed cardiac medications (ACE inhibitors, beta-blockers, diuretics) as directed
• 5Reduce alcohol consumption and avoid smoking
• 6Manage stress through relaxation techniques and regular follow-up echocardiography

When to Test

Fractional shortening is measured via transthoracic echocardiography when there is clinical suspicion of cardiac dysfunction, during evaluation of heart failure, cardiomyopathy, valvular disease, or other structural heart conditions. It is also useful for baseline assessment and periodic monitoring in patients with known cardiac disease.

Related Biomarkers